$11.28+0.07 (+0.62%)
The Hackett Group, Inc.
The Hackett Group, Inc. in the Technology sector is trading at $11.28 with a market capitalization of $273M. Wall Street consensus targets $16.67 (3 analysts), implying a +47.8% move over the next 12 months. The stock is currently near its 52-week low of $9.16, remaining 17.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $69.33M↑ | $68.80M↓ | $75.75M↑ | $73.11M↓ | $78.90M |
| Gross Profit | $27.71M↓ | $29.34M↓ | $31.62M↑ | $29.73M↑ | $27.96M |
| Operating Income | $8.20M↓ | $10.89M↑ | $9.08M↑ | $8.57M↑ | $4.59M |
| Net Income | $4.41M↑ | $4.28M↓ | $5.59M↑ | $2.55M↑ | $1.66M |
The Hackett Group, Inc. operates as an intellectual property platform-based generative artificial intelligence strategic consulting and executive advisory digital transformation in the United States, Europe, and internationally. The company offers Ha...
The Hackett Group found semiconductor revenue jumped 32% last year as AI demand surged, but turning that growth into cash is taking longer.
New data from The Hackett Group found pharma’s cash conversion cycle climbed to nearly 186 days in 2025 as firms increased investment in biologics and GLP-1s.

AI-enabled platform transition drives $30M in contract wins and margin expansion.
Moby summary of The Hackett Group, Inc.'s Q2 2026 earnings call
The research firm’s latest working capital survey demonstrates the “growing amount of liquidity trapped on corporate balance sheets.”